830 nm photobiomodulation therapy promotes engraftment of human umbilical cord blood-derived hematopoietic stem cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
830 nm photobiomodulation therapy promotes engraftment of human umbilical cord blood-derived hematopoietic stem cells ; volume:10 ; number:1 ; day:12 ; month:11 ; year:2020 ; pages:1-8 ; date:12.2020
Scientific reports ; 10, Heft 1 (12.11.2020), 1-8, 12.2020
- Creator
-
Yang, Jingke
Wang, Li
Wu, Mei X.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-76760-5
- URN
-
urn:nbn:de:101:1-2020121909463178317874
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yang, Jingke
- Wang, Li
- Wu, Mei X.
- SpringerLink (Online service)
Other Objects (12)
Tumorigenicity Evaluation of Umbilical Cord Blood-derived Mesenchymal Stem Cells
Umbilical cord blood-derived exosomes attenuate dopaminergic neuron damage of Parkinson's disease mouse model
PRC2 inhibition counteracts the culture-associated loss of engraftment potential of human cord blood-derived hematopoietic stem/progenitor cells
Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation for Patients with Decompensated Liver Cirrhosis
Culture and differentiation of cytokine-induced killer cells from umbilical cord blood-derived mononuclear cells
PRC2 inhibition counteracts the culture-associated loss of engraftment potential of human cord blood-derived hematopoietic stem and progenitor cells
PRC2 inhibition counteracts the culture-associated loss of engraftment potential of human cord blood-derived hematopoietic stem and progenitor cells
Good manufacturing practice-compliant isolation and culture of human umbilical cord blood-derived mesenchymal stem cells
Human umbilical cord blood-derived mononuclear cell transplantation: case series of 30 subjects with Hereditary Ataxia
Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis
CAPE promotes the expansion of human umbilical cord blood-derived hematopoietic stem and progenitor cells in vitro
Correction to: Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis
Tumorigenicity Evaluation of Umbilical Cord Blood-derived Mesenchymal Stem Cells
Umbilical cord blood-derived exosomes attenuate dopaminergic neuron damage of Parkinson's disease mouse model
PRC2 inhibition counteracts the culture-associated loss of engraftment potential of human cord blood-derived hematopoietic stem/progenitor cells
Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation for Patients with Decompensated Liver Cirrhosis
Culture and differentiation of cytokine-induced killer cells from umbilical cord blood-derived mononuclear cells
PRC2 inhibition counteracts the culture-associated loss of engraftment potential of human cord blood-derived hematopoietic stem and progenitor cells
PRC2 inhibition counteracts the culture-associated loss of engraftment potential of human cord blood-derived hematopoietic stem and progenitor cells
Good manufacturing practice-compliant isolation and culture of human umbilical cord blood-derived mesenchymal stem cells
Human umbilical cord blood-derived mononuclear cell transplantation: case series of 30 subjects with Hereditary Ataxia
Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis
CAPE promotes the expansion of human umbilical cord blood-derived hematopoietic stem and progenitor cells in vitro
Correction to: Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis
Tumorigenicity Evaluation of Umbilical Cord Blood-derived Mesenchymal Stem Cells
Umbilical cord blood-derived exosomes attenuate dopaminergic neuron damage of Parkinson's disease mouse model
PRC2 inhibition counteracts the culture-associated loss of engraftment potential of human cord blood-derived hematopoietic stem/progenitor cells
Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation for Patients with Decompensated Liver Cirrhosis
Culture and differentiation of cytokine-induced killer cells from umbilical cord blood-derived mononuclear cells
PRC2 inhibition counteracts the culture-associated loss of engraftment potential of human cord blood-derived hematopoietic stem and progenitor cells
PRC2 inhibition counteracts the culture-associated loss of engraftment potential of human cord blood-derived hematopoietic stem and progenitor cells
Good manufacturing practice-compliant isolation and culture of human umbilical cord blood-derived mesenchymal stem cells
Human umbilical cord blood-derived mononuclear cell transplantation: case series of 30 subjects with Hereditary Ataxia
Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis
CAPE promotes the expansion of human umbilical cord blood-derived hematopoietic stem and progenitor cells in vitro